Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
643 |
|
| Actual shortage: | 17 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 85 (13%) | |
| Resolved: | 541 (84%) | |
Discontinuation Reports |
233 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 233 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
80 (9%) |
|
Overdue reports |
1 (6%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-29 | 2019-01-22 | 65715 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-12-05 | 2019-03-21 | 68773 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-28 | 2019-04-11 | 79724 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-10 | 2019-07-30 | 81068 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-07-16 | 2019-07-24 | 89459 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-07 | 2019-08-20 | 91041 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-08-07 | 2020-01-17 | 91047 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Avoided shortage | 2020-01-23 | 2020-03-25 | 104079 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-28 | 2020-03-26 | 104631 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-28 | 2020-06-03 | 104638 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-29 | 2020-06-10 | 104685 |
| MYLAN-NIFEDIPINE EXTENDED RELEASE | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-29 | 2020-06-10 | 104688 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2020-07-01 | 110465 |
| MYLAN-VERAPAMIL SR | 120MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-04-02 | 2021-03-09 | 110509 |
| MYLAN-VERAPAMIL SR | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-21 | 2021-03-17 | 120686 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-28 | 2020-12-01 | 121246 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-06 | 2022-08-25 | 125767 |
| MYLAN-VERAPAMIL SR | 240MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-05 | 2021-03-17 | 130850 |
| MYLAN-GLICLAZIDE MR | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-01-20 | 2021-02-24 | 132033 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-02-09 | 2022-08-25 | 133595 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Discontinued | 2018-07-10 | 2018-07-11 | 55141 |
| MYLAN-BUPROPION XL | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167806 |
| MYLAN-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-08-25 | 2022-08-25 | 167819 |
| MYLAN-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16009 |
| MYLAN-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16012 |
| MYLAN-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16015 |
| MYLAN-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-07-17 | 2017-07-17 | 16018 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |